Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT04706195
Recruiting Not applicable

Early Accessible Person-centred Rehabilitation for Patients With Chronic Pain

NCT04706195 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2021-08-15
Last updated
2023-07-05

Condition(s) studied

Chronic Pain

Investigational drug(s) / intervention(s)

Person-centred care at distance through an eHealth platform

Person-centred care at distance through an eHealth platform: Person-centred care at distance through an eHealth platform, used by professionals, patients and relatives

Study summary

The goal of the research project EAPER-P is to evaluate PCC person-centred care (PCC) in the form of a combined eHealth and telephone support for patents with chronic pain. A developed PCC eHealth platform, together with person-centred telephone conversations, will be used as a tool to identify patients´ resources to enhance coping and living with their illness by means of a dialog and partnership with staff and relatives. PCC in the form of a combined eHealth and telephone support will not replace, but instead be used as add on treatment to usual care (guideline directed care).

In addition, a process evaluation of the intervention will be performed in order to evaluate the mechanisms behind the intervention and evaluate which parts of the interventions the participants find useful.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Men and women 18-65 years old. * Living with chronic, non-malignant, pain with any of the following diagnoses: M25, M54, M79 and R52 * On sick leave (full or part time) from paid professional work. * Willing to participate Exclusion Criteria: * Full time sick leave \>24 months (part time sick leave \>24 months can be included). * Severe impairment (cognitive or other) that prevents patient from using the eHealth support * No registered address * Not willing to participate * Any severe disease with an expected survival \<12 months * Ongoing documented diagnosis of alcohol or drug abuse * Other severe disease that can interfere with follow-up or if the intervention is assessed as a burden * Patient participating in another conflicting randomized study * Patients not understanding spoken and written Swedish * Patient not having access to a device with internet access

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Primary care Gothenburg Sweden Recruiting

More Göteborg University trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04706195 on ClinicalTrials.gov ↗ ← All trials in Sweden